Director at Vertex (NASDAQ: VRTX) receives 2,866 fully vested options

Rhea-AI Filing Summary

Vertex Pharmaceuticals director Bruce I. Sachs reported an acquisition of stock options as compensation. He received a grant of 2,866 stock options for Vertex common stock at an exercise price of $424.45 per share. The options are fully vested and expire on April 30, 2036, and his direct derivative holdings after this grant total 2,866 options.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SACHS BRUCE I

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,866	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 2,866 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 2,866 options Exercise price: $424.45 per share Expiration date: April 30, 2036 +1 more

4 metrics

Options granted 2,866 options Stock Option (Right to Buy) grant on May 1, 2026

Exercise price $424.45 per share Conversion or exercise price for granted options

Expiration date April 30, 2036 Option expiration for the 2,866 granted options

Derivative holdings after grant 2,866 options Total derivative securities following transaction

Key Terms

Stock Option (Right to Buy), exercise price, expiration date, Common Stock

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 424.4500"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-04-30T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Common Stock financial

"underlying_security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACHS BRUCE I

(Last) (First) (Middle)

C/O VERTEX PHARMACEUTICALS INCORPORATED

50 NORTHERN AVE

(Street)

BOSTON MASSACHUSETTS 02210

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERTEX PHARMACEUTICALS INC / MA [ VRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$424.45	05/01/2026		A		2,866		(1)	04/30/2036	Common Stock	2,866	$0	2,866	D

Explanation of Responses:

1. Fully vested.

Remarks:

	/s/ Christiana Stevenson, Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did VRTX director Bruce I. Sachs report?

Bruce I. Sachs reported receiving 2,866 stock options for Vertex common stock as a compensation grant. The options carry a $424.45 exercise price and are fully vested, with an expiration date of April 30, 2036, according to the Form 4 data.

What is the exercise price of Bruce I. Sachs’s VRTX stock options?

The granted VRTX stock options have an exercise price of $424.45 per share. This means Sachs can buy Vertex common stock at $424.45 under the option terms until the options expire on April 30, 2036, if other plan conditions are met.

How many VRTX stock options does Bruce I. Sachs hold after this Form 4?

Following this transaction, Bruce I. Sachs directly holds 2,866 stock options as reported in the filing. These options are fully vested and relate to Vertex common stock, with a $424.45 exercise price and an April 30, 2036 expiration.

Are Bruce I. Sachs’s newly granted VRTX options already vested?

Yes. A footnote in the Form 4 states the 2,866 stock options are fully vested. This means Sachs does not need additional service time for vesting and can exercise them under the plan terms before their April 30, 2036 expiration.

When do Bruce I. Sachs’s VRTX stock options expire?

The granted Vertex stock options held by Bruce I. Sachs expire on April 30, 2036. After this expiration date, the right to buy Vertex common stock at the $424.45 exercise price lapses, based on the Form 4 disclosure details.